2022 Symposium Speakers

"Long-term efficacy and safety of elamipretide in patients with Barth syndrome: open label extension results of TAZPOWER through 168 weeks"

"Engineered isoforms of Tafazzin: activity, stability, and potental therapeutic utility"

"Activation of stress response signaling rewires cardiac metabolism in Barth syndrome"

"Advances in understanding cardiolipin synthesis and pathological effects of dysregulation in cells and animals"

"Quality of life in Barth syndrome"

"Barth syndrome’s unsung phenotype: 3-methylglutaconic aciduria"

"The molecular composition of cardiolipins is tightly coupled with the nutrional lipid environment"

"The Barth Syndrome Arrhythmia Project"

"Qualitative and quantitative measure of fatigue in Barth syndrome"

"Cardiolipin coordinates lipolysaccharide-induced respiratory Complex II diassembly & degradation"

"Cardiolipin bound to mitochondrial ADP/ATP carrier supports the structure and transport-related function"

"The Barth Syndrome Arrhythmia Project"

"Longitudinal observational study of cardiac outcome risk factor prediction in
children, adolescents, and adults with Barth syndrome"

"Cardiolipin metabolism regulates myoD1 expression and muscle development"

"Genomewide association study in a mouse model of Barth syndrome"

"Extended recovery of cardiac function after severe infantile cardiomyopathy
presentation in Barth syndrome"